Börse:
47,623€
-0,29%
Echtzeit-Aktienkurs Eagle Pharmaceuticals
Bid:
47,500€
Ask:
47,745€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 662,62 Mio. EUR (13,91 Mio. x 47,623€) | |
| Website: | - | |
| Sektor: | Medizin / Pharmaunternehmen | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 3,85 | 2,99 | 3,11 |
| KGV | 9,60 | 14,56 | 22,81 |
| Div. Rend. | - | - | - |
Echtzeit-Chart der Eagle Pharmaceuticals Aktie
Börsenkurse Eagle Pharmaceuticals
| Börse Stuttgart | 47,045€ | 2000 | 48,220€ | 2000 | 47,633€ | 3,08% |
| Tradegate | 47,500€ | 640 | 47,745€ | 630 | 47,623€ | -0,61% |
| Dollar Indikation | 53,236$ | 0 | 53,570$ | 0 | 53,403$ | -0,61% |
| Lang & Schwarz | 47,528€ | 523 | 47,748€ | 523 | 47,638€ | -0,65% |
| Euro Indikation | 47,500€ | 0 | 47,745€ | 0 | 47,623€ | -0,29% |
Fundamentaldaten der Eagle Pharmaceuticals Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 213,31 Mio. | 34,04 Mio. | 31,90 Mio. | 2,09 | 0,00% | 22,81 | 3,11 |
| 2017 | 236,71 Mio. | 72,95 Mio. | 51,94 Mio. | 3,27 | 0,00% | 14,56 | 2,99 |
| 2016 | 189,48 Mio. | 53,43 Mio. | 81,45 Mio. | 4,96 | 0,00% | 9,60 | 3,85 |
Profil der Eagle Pharmaceuticals Aktie
Eagle Pharmaceuticals, Inc. is a pharmaceutical company engages in the provision of injectable products. Its activities include development and commercialization of pharmaceutical products for the treatment of areas such as critical care, orphan diseases, and oncology. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.Anlagetrends zur Eagle Pharmaceuticals Aktie
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen